Institutional Research Cancer Epidemiology Fellowship

本申请为T32 CA09314-癌症培训计划的5年续期(34-38年) 约翰霍普金斯大学彭博公共卫生学院的流行病学、预防和控制。我们的使命是 培养博士后学生和博士后研究员成为推动知识进步的前沿领导者) 癌症的原因，包括地方、国家和地区人口中的固有和可改变的因素 全球；b)如何通过下列方式预防和减轻地方、国家和全球的癌症负担 更好地了解影响癌症发展和促进健康的行为 存活率，二)确定癌症早期检测的新标记物，三)识别和处理癌症 包括弱势群体的差异和护理障碍；以及c)如何翻译、实施和 评估癌症流行病学、预防和控制人群中的发现。我们的目标是创造一个富有的 通过高度创新、高效率和协作性的癌症增强学员的互动环境 由公共卫生和临床学院的观察性、基础性和临床科学家进行的研究 医学和癌症中心。该计划有3个方面：1)癌症病因和预防，包括 翻译研究；2)癌症遗传流行病学，包括基因组学和表观遗传学；3)癌症 控制，包括差异、沟通和烟草。6名博士后和3名博士后学员专注于 跨轨道共享要素方案：关于实质性和方法论主题的教学课程和 研究伦理；互动信息交流；教学、交流、资助撰写；博士后或博士后 研究；以及针对特定项目的教育、研究和职业指导。我们强调……的重要性 开发和测试新的假设，并进行跨学科合作。通过共享元素、受训者 暴露在当前的主题中，如翻译研究，分子流行病学，新出现的风险因素， 研究和筛查的方法学问题、差异、沟通和流行病学在风险中的应用 评估和公共政策。16个P受体，部分用于建议和研究记录，是主要的 导师。28家分支机构提供特定癌症、生物统计学和实验室暴露方面的尖端专业知识 评估。与主任一起，指导委员会负责挑选/监测受训人员，以及 随着癌症研究的发展，程序也在不断完善。博士后和博士后培训时间分别为4-5年和2年 实习生。我们有很好的记录：过去10年，33名博士后和15名博士后实习生患上了癌症 研究、培训和事业成功。从一大批申请者中，招聘出最好的应聘者。实习生 代表不同的背景；我们收到了4种治愈补充剂。总而言之，该计划旨在实现) 为学员提供必要的多学科背景，以进行最高水平、最先进的、 合作、翻译的癌症研究，b)培养他们成为创新的思考者，c)发展教学和 沟通技能，d)让他们做好准备，在学术界或其他地方领导国家的癌症研究议程。

This application is for a 5-year renewal (Years 34-38) of T32 CA09314 - Training Program in Cancer Epidemiology, Prevention, and Control at Johns Hopkins Bloomberg School of Public Health. Our mission is to train pre-doctoral students and post-doctoral fellows to be leaders at the forefront of advancing knowledge of a) causes of cancer, including inherent and modifiable factors in human populations locally, nationally, and globally; b) how to prevent and reduce burden of cancer locally, nationally, and globally by i) providing and communicating a better understanding of behaviors that influence cancer development and promote healthy survivorship, ii) identifying new markers for early detection of cancer, and iii) identifying and addressing cancer disparities including in vulnerable populations and barriers to care; and c) how to translate, implement, and evaluate cancer epidemiology, prevention, and control discoveries into populations. Our goal is to create a rich and interactive environment for trainees augmented by highly innovative, productive, and collaborative cancer research conducted by observational, basic, and clinical scientists at the Schools of Public Health and Medicine and Cancer Center. The Program has 3 tracks: 1) Cancer Etiology and Prevention, including translational research; 2) Genetic Epidemiology of Cancer, including genomics and epigenetics; and 3) Cancer Control, including disparities, communication, and tobacco. 6 pre- and 3 post-doctoral trainees pursue focused programs of shared elements across tracks: didactic courses on substantive and methodologic topics and research ethics; interactive information exchange; teaching, communication, grant writing; pre- or post-doctoral research; and program-specific education, research, and career mentoring. We stress the importance of developing and testing novel hypotheses and collaborating across disciplines. Via shared elements, trainees are exposed to current topics such as translational research, molecular epidemiology, emerging risk factors, methodologic issues in research and screening, disparities, communication, and use of epidemiology in risk assessment and public policy. 16 Preceptors, selected in part for records of advising and research, are primary mentors. 28 Affiliates provide cutting-edge expertise in specific cancers, biostatistics, and laboratory exposure assessment. With the Director, the Steering Committee is responsible for trainee selection/monitoring, and program refinement as cancer research evolves. Training duration is 4-5 yrs for pre- and 2 yrs for post-doctoral trainees. We have a strong record: the 33 pre- and 15 post-doctoral trainees in the past 10 years had cancer research training and career success. From a large pool of applicants, best candidates are recruited. Trainees represent diverse backgrounds; we received 4 CURE supplements. In summary, the Program is designed to a) provide trainees with a multidisciplinary background essential to conduct highest caliber, state-of-the-art, collaborative, translational cancer research, b) nurture them to be innovative thinkers, c) develop teaching and communication skills, d) prepare them to lead the nation's cancer research agenda in academia or elsewhere.